Clinical Trials Logo
  1. Home
  2. GI Cancer
  3. NCT00798447

Efficacy and Safety of a PN Regimen Containing n-3 Fatty Acid in Patients Considered After GI Surgery

GI Cancer Clinical Trial

Official title:
A Prospective, Randomized, Double Blind Study to Compare the Efficacy and Safety of a n-3 Fatty Acid-containing Lipid Emulsion During Parenteral Nutrition in Patients Considered for Major Surgery for Gastric and Colorectal Cancer.

Clinical Trial Summary

Evaluation of the impact of peri- and post-operative parenteral nutrition enriched with n-3 PUFA on post-operative inflammatory processes.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00798447
Study type Interventional
Source B. Braun Melsungen AG
Contact
Status Completed
Phase Phase 3
Start date November 2008
Completion date October 2010
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04931420 - Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels Phase 2
Completed NCT04091165 - Mobile APP Utilization for Enhanced Post-Operative Nutritional Recovery
Completed NCT00633334 - Development of Early Detection Signs for Gastrointestinal Cancer
Completed NCT03676426 - Comparison of a Web-based Advance Directive to a Standard Advance Directive N/A
Completed NCT02594696 - Proactive Psychiatry Consultation for Patients With Cancer and Severe Mental Illness N/A
Recruiting NCT05142033 - Avera Cancer Sequencing and Analytics Protocol (ASAP)
Completed NCT03530969 - Geriatric Communication Skills Training Program for Oncology Clinicians N/A
Terminated NCT04731441 - Exercise Intervention Prior to CRS-HIPEC: Feasibility & Impact N/A
Recruiting NCT05804331 - The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
Terminated NCT05368688 - Microbiome in Colorectal Cancer Onset and Progression
Recruiting NCT05313191 - Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors N/A
Completed NCT02871115 - Pilot Study of a Pharmacy Intervention for Older Adults With Cancer N/A
Recruiting NCT03812796 - Epigenetic Modulation of the immunE Response in GastrointEstinal Cancers (EMERGE) Phase 2
Recruiting NCT04774679 - Macroscopic on Cite Evaluation of EUS-FNA Specimen With 22 G Needle N/A
Recruiting NCT02675946 - CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596) Phase 1
Recruiting NCT06040801 - Effect of Geriatric Intervention in Frail Patients With Gastric, Biliary, and Pancreatic Cancer Receiving Palliative Chemotherapy N/A
Completed NCT01160367 - Trial of Ascertaining Individual Preferences for Loved One's Role in End-of-Life N/A
Recruiting NCT05767697 - Genomics and Prognosis in GI Cancers